Machinery & Materials
Logistics & Cold Chain
U.S. Pharmacopeial Convention (USP)
More from U.S. Pharmacopeial Convention (USP)
Syringe, IV Bag Compounding/Filling Systems Fulfill ‘Mission’: Part I
Two automated IV compounding systems sterile-fill liquids and lyophilized products into IV syringes and bags for administration to Mission Health patients.
Jan 18th, 2019
Managing the Risks of Temperature Excursions
Baxter’s voluntary recall serves as a reminder of the importance of managing life science product temperatures through the supply chain.
Oct 6th, 2017
Local-Area Science Organization Pledges Support to Rockville Science Center
On Tuesday, January 19, 2016, the United States Pharmacopeial Convention will host a celebratory reception acknowledging its support of the Rockville Science Center.
Jan 16th, 2016
Salah Kivlighn, Ph.D., Named Senior VP of Strategic Marketing and Program Operations at USP
Dr. Kivlighn reports to USP’s Chief Executive Officer, Ronald T. Piervincenzi, and is a member of the organization’s executive team.
Dec 21st, 2015
Robert Femia, Ph.D., Named Senior VP of Chemical Medicines and General Chapters at USP
The United States Pharmacopeial Convention announced that Robert Femia, Ph.D., has assumed the role of Senior Vice President, Chemical Medicines and General Chapters. Femia reports to USP’s Chief Science Officer and Executive Vice President, Jaap Venema, and has responsibility for industry standards collaboration as well as chemical medicine monograph and general chapter standards in USP’s compendia, United States Pharmacopeia—National Formulary.
Dec 2nd, 2015
No Affiliation Between US Pharmacopeia (USP) and USP Labs -- USP Public Standards Promote Supplement Quality, Protect Public Health
USP’s public standards are recognized in US Law, enforceable by the FDA and used in nearly 140 countries to ensure supply chain integrity, medicine and supplement quality
Nov 19th, 2015
USP Submits Comments on Proposed Rule for Naming Certain Biologics
Changes to Established System Could Cause Unintended Consequences
Nov 17th, 2015
USP comments on FDA Draft Guidance on nonproprietary naming of biologics
USP supports a uniform and scientifically-based approach to naming that does not create unintended risks for patients and practitioners
Oct 30th, 2015
Anthony Lakavage, J.D., Named USP Senior VP of Global External Affairs
The United States Pharmacopeial Convention (USP) today announced that Anthony (Tony) Lakavage, J.D., will become Senior Vice President, Global External Affairs, beginning on September 14.
Sep 8th, 2015